Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Research area

Phase 1 Pancreatic Cancer trials

Studies in pancreatic cancer examine investigational medications, combinations of therapies, and methods for early detection. At Phase 1 Cancer Trials, we can help you learn whether a study may be a fit for you.

Updated

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Phase 1 pancreatic cancer studies in numbers

Phase 1 pancreatic cancer studies recruiting in the U.S.
166
states with a study site
34
studies that accept healthy volunteers
1

Source: ClinicalTrials.gov. Data processed .

Find Phase 1 pancreatic cancer studies by state

These states have the most studies recruiting right now.

Phase 1 pancreatic cancer studies recruiting now

As of November 17, 2026, 166 Phase 1 pancreatic cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry. This is what they have in common.

What they test

  • medications145
  • biologics such as vaccines or antibodies28
  • procedures14
  • combination products6
  • devices6

A study can test more than one.

Main purpose

  • treating a condition153
  • diagnosis7
  • other purposes3
  • device feasibility1

Phase

  • Early Phase 17
  • Phase 196
  • Phase 1/263

Who runs them

  • industry108
  • university, hospital or other51
  • government7

Who they enroll

  • adults (18 to 64)166
  • older adults (65 and over)163
  • children (under 18)5

1 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 166 studies.

Recently updated Phase 1 pancreatic cancer studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

    • Early Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    University of Arizona
    Recruiting in
    Tucson, AZ
    Registry record
    NCT07627191 · updated
  2. A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Boston, MA · Durham, NC · New York, NY
    Registry record
    NCT07024615 · updated
  3. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Boston, MA · Chicago, IL · Columbus, OH · and 9 more U.S. locations
    Registry record
    NCT05372614 · updated
  4. Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Recruiting in
    St Louis, MO
    Registry record
    NCT06141031 · updated
  5. Lm-LLO-TT and Gemcitabine in Unresectable Pancreatic Ductal Adenocarcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Loki Therapeutics, Inc.
    Recruiting in
    The Bronx, NY
    Registry record
    NCT07828236 · updated
  6. Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Oklahoma
    Recruiting in
    Oklahoma City, OK
    Registry record
    NCT07829185 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in the United States on ClinicalTrials.gov.

What pancreatic cancer studies look at

Research into pancreatic cancer covers investigational medications, therapies used in combination, and methods for early detection. What a study would ask of you changes from one to the next, since each is designed to answer a single, specific question.

Whatever a trial is testing is investigational. Its risks and how well it works remain open questions for researchers, which is the reason the trial exists.

Who may be able to take part

Each Phase 1 trial sets requirements of its own. These may cover your age, your health history, the medications you take now, and how the condition affects you. There are also studies that take participants without the condition.

You are not expected to judge your own eligibility. That check belongs to the study team, who carry it out during a screening visit. Our guide to eligibility and screening explains the process.

What taking part usually involves

  1. A first conversation

    You start by talking with a coordinator, who gives a general outline of the study and takes your questions. Nothing else happens until that conversation is done.

  2. Informed consent

    Next comes the written information. The study team sets out every detail on paper, known risks included, and whether to agree is your decision.

  3. Screening

    Suitability is checked with tests and questions about your health. Being screened does not always lead to taking part.

  4. Study visits

    Once you join a Phase 1 pancreatic cancer trial, your visits are planned ahead of time. The study team checks on your health at each one. You remain free to leave the study whenever you choose.

Questions about Phase 1 pancreatic cancer studies

Do I need a diagnosis to join a study about pancreatic cancer?

The answer varies from one Phase 1 pancreatic cancer trial to the next. A confirmed diagnosis is an entry requirement for certain studies, while the screening step itself includes an assessment for the rest. Which of these applies to you is something the study team will explain.

Would I have to change the care I receive now?

Changes to your care are not something to make by yourself. Studies differ: current care can carry on in some and not in others. This is reviewed with you by the study doctor, and you are welcome to talk it through with your own doctor ahead of any decision.

Is there a cost to take part?

In general, participants pay nothing for the visits, tests and medication that belong to a study. Find out more about costs.

Ask about Phase 1 pancreatic cancer studies

We only need a few details from you. A coordinator then gets in touch, and asking commits you to nothing.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call